Statistics for Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus
Total visits
| views | |
|---|---|
| Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus | 155 |
Total visits per month
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
File Visits
| views | |
|---|---|
| CCRP.2015.831260.pdf | 107 |
| CCRP.2015.831260.xml | 53 |
Top country views
| views | |
|---|---|
| United States | 58 |
| Canada | 18 |
| Germany | 10 |
| Ireland | 10 |
| China | 6 |
| Finland | 5 |
| United Kingdom | 4 |
| Russia | 2 |
| Ukraine | 2 |
| Cyprus | 1 |
| France | 1 |
| Singapore | 1 |
Top city views
| views | |
|---|---|
| Ashburn | 39 |
| Winnipeg | 17 |
| Dublin | 10 |
| Inglewood | 10 |
| Beijing | 3 |
| Helsinki | 3 |
| Burton-on-Trent | 2 |
| Zhengzhou | 2 |
| Boardman | 1 |
| Changzhou | 1 |
| Des Moines | 1 |
| Los Angeles | 1 |
| Mountain View | 1 |
| Nagold | 1 |
| Seattle | 1 |
| Singapore | 1 |
| Thornhill | 1 |